Artificial Blood Market

The global Artificial Blood market was valued at US$ 3130.7 million in 2022 and is projected to reach US$ 6541.4 million by 2029, at a CAGR of 11.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Artificial blood, also called oxygen therapeutics or hemoglobin-based oxygen carriers, offer the promise of new life-saving medical treatments.
Artificial Blood Market aims to provide a comprehensive presentation of the global market for Artificial Blood, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood. Artificial Blood Market contains market size and forecasts of Artificial Blood in global, including the following market information:
Global Artificial Blood Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
Artificial blood or synthetic blood and blood products are the alternatives to the blood transfusion to replace the blood. It fulfills and replicates the normal functions of the body. Artificial blood is infused in the traumatic injuries and other disease conditions for the transportation of carbon di oxide and oxygen across the body.
We surveyed the Artificial Blood companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• Human Blood
• Synthetic Blood
• Animal Blood

• Hemoglobin-Based Oxygen Carriers (HBOCs)
• Perflurocarbon Emulsions (PFCEs)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Artificial Blood revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Artificial Blood revenues share in global market, 2022 (%)

• Dextro-Sang Corporation
• BioPure Corporation
• Sangart
• Northfield Laboratories
• Baxter International
• Dentritech
• FluorO2 Therapeutics
• Nuvox Pharma
• Alpha Therapeutic Corporation
• HemoBioTech

• Chapter 1: Introduces the definition of Artificial Blood, market overview.
• Chapter 2: Global Artificial Blood market size in revenue.
• Chapter 3: Detailed analysis of Artificial Blood company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Artificial Blood in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: The main points and conclusions of the report.